The global infection control market is projected to increase from USD 58.8 billion in 2026 to USD 108.3 billion by 2036, expanding at a compound annual growth rate (CAGR) of 6.3%, according to Fact.MR. The market was valued at USD 55.3 billion in 2025. Demand is supported by the need to strengthen infection prevention protocols across hospitals, laboratories, clinics, pharmaceutical facilities, and other healthcare environments.

Infection control encompasses products and technologies used to prevent the spread of infectious agents and maintain hygienic conditions. Disinfectants, antiseptics, sterilization products, cleaning solutions, protective barriers, and specialized disinfection devices play important roles in healthcare operations. As healthcare providers focus on patient safety and infection prevention, reliable products and standardized cleaning and sterilization procedures remain essential.

Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.factmr.com/connectus/sample?flag=S&rep_id=12362

Disinfectants Lead Product Demand

Disinfectants are expected to remain the leading product segment in 2026, supported by their broad use in healthcare facilities and other environments requiring routine surface and equipment hygiene. Liquid disinfectants, surface disinfectant sprays, and high-level disinfectants serve different cleaning and decontamination requirements.

By application, surface disinfection is projected to account for 37.8% of the market in 2026. Hospitals, laboratories, and public facilities rely on surface disinfection protocols to reduce contamination risks in frequently used spaces. Instrument sterilization and hand hygiene also contribute to demand, particularly in settings where infection prevention procedures are closely integrated into daily operations.

Chemical-based disinfection is expected to lead the technology segment, supported by established use of chlorine-based systems, alcohol-based solutions, and quaternary ammonium compounds. Liquid products are also projected to lead the product-form segment, reflecting their established role in cleaning and disinfection workflows.

Regional Outlook: India and China Drive Growth

India is projected to register the fastest growth among the countries analyzed, with a CAGR of 8.3% through 2036. Expanding healthcare access, hospital infrastructure development, and increasing adoption of infection prevention practices are supporting market opportunities.

China follows with a projected CAGR of 7.7%, reflecting investment in healthcare facilities and domestic manufacturing capacity. The United States is forecast to grow at 5.8%, while Germany is expected to record a CAGR of 5.1%. Brazil and Saudi Arabia are projected to expand at 4.9% and 4.4%, respectively. Japan is forecast to register a CAGR of 3.8% over the same period.

Analyst Perspective

Shambhu Nath Jha, Principal Consultant at Fact.MR, identifies geographic expansion, healthcare access, and effective distribution as important factors shaping the market's development. As demand expands across established and emerging healthcare systems, manufacturers will need to balance product performance, regulatory requirements, and affordability.

The market also faces challenges from procurement cost pressures, differences in regulatory requirements, and limited access to specialized infection prevention infrastructure in some emerging markets. Suppliers that combine dependable product quality with broad distribution and technical support can strengthen their position across healthcare settings.

Competitive Landscape

The infection control market includes established medical technology and sterilization companies with portfolios covering disinfection, instrument processing, and healthcare hygiene. Key companies profiled by Fact.MR include STERIS plc, 3M Company, Getinge AB, Belimed AG, Advanced Sterilization Products (ASP), MMM Münchener Medizin Mechanik GmbH, Medivators Inc., Cantel Medical LLC (now part of STERIS plc), O&M Halyard, Inc., Midmark Corporation, and W&H Dentalwerk Bürmoos GmbH.

Competition is shaped by product reliability, regulatory compliance, portfolio breadth, distribution networks, and the ability to support healthcare facilities with integrated infection prevention solutions. Established players are positioned to serve institutional buyers through specialized equipment, consumables, and service capabilities.

Market Snapshot

• Market size (2025): USD 55.3 billion
• Estimated market size (2026): USD 58.8 billion
• Forecast market size (2036): USD 108.3 billion
• CAGR (2026–2036): 6.3%
• Leading product segment: Disinfectants
• Leading application: Surface disinfection (37.8% share in 2026)
• Leading technology: Chemical-based disinfection
• Leading product form: Liquid
• Fastest-growing country: India (8.3% CAGR)
• China growth outlook: 7.7% CAGR

To View Related Reports

https://sites.google.com/view/factmrinsights/report/preeclampsia-market-approaches-usd-3-47-billion-by-2036-with-8-9-annual-gr

https://afgbfh.blogspot.com/2026/10/preeclampsia-market-forecast-indicates.html

https://sohomoy.com/blogs/73285/Preeclampsia-Market-to-Attain-USD-3-47-Billion-by-2036

https://social.art-inpa.com/blogs/42986/Preeclampsia-Market-Growth-Trajectory-Points-to-USD-3-47-Billion

About Fact.MR

Fact.MR is a market research and competitive intelligence provider delivering market intelligence, competitive analysis, and forecasting across global industries. Its research helps businesses evaluate market demand, understand competitive developments, and identify growth opportunities.